SCHEMBL9655756

SCHEMBL9655756

Cc1c(C=CC(=O)c2ccccc2)ncn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.46
NPC1 O15118 6/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 3/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 5/20 0.43
CYP3A4 P08684 3/20 0.43
NFKB1 P19838 3/20 0.43
NFKB2 Q00653 3/20 0.43
RELA Q04206 3/20 0.43
CYP1B1 Q16678 3/20 0.42
LMNA P02545 3/20 0.42
MAOB P27338 3/20 0.42
BCHE P06276 3/20 0.42
RECQL P46063 2/20 0.42
PLIN1 O60240 1/20 0.42
TNFRSF1A P19438 1/20 0.42
ACHE P22303 1/20 0.42
PLIN5 Q00G26 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9655749 1.00 RAB9A (0.46) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL9654312 0.90 MAOB (0.41) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL9654296 0.90 MAOB (0.41) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL9656720 0.87 CYP1B1 (0.50) ALDH1A1SMN1; SMN2HPGDKDM4EMAPT
SCHEMBL9656710 0.87 CYP1B1 (0.50) ALDH1A1SMN1; SMN2HPGDKDM4EMAPT
SCHEMBL7319467 0.84 NR4A2 (0.38) NPC1SMN1; SMN2KDM4EMAPTKMT2A
SCHEMBL7325023 0.84 NR4A2 (0.38) NPC1SMN1; SMN2KDM4EMAPTKMT2A
SCHEMBL9656194 0.83 CYP1B1 (0.44) ALDH1A1HPGDKDM4EMAPTCYP3A4
SCHEMBL9656211 0.83 CYP1B1 (0.44) ALDH1A1HPGDKDM4EMAPTCYP3A4
SCHEMBL9655717 0.81 ABCG2 (0.43) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5084474-A Antagonist of 5-hydroxytryptamine receptors on nerves and useful for treatment of psychotic disorders, anxiety, and nausea and vomiting, compounds of imidazole GLAXO GROUP LIMITED (GB) 1992-01-28 US disclosed
US-5019586-A 5-Hydroxytryptamine Receptor Antagonists GLAXO GROUP LIMITED 1991-05-28 US disclosed
US-4918080-A ANXIOLYTIC AGENTS, ANTIEMETICS GLAXO GROUP LIMITED (GB) 1990-04-17 US disclosed
EP-0291172-A1 Ketone derivatives GLAXO GROUP LIMITED (GB) 1988-11-17 EP disclosed